corporate_fare

European Group for Research in Schizophrenia Stichting

Address
Retstraat 13

Sponsor Overview

assignment
1
sponsored trial
science
2
molecules
location_city
15
research centres
public
9
countries
person_search
15
investigators

Specializations

Schizophrenia Research

The sponsor’s clinical research is centered on schizophrenia, with particular attention to symptoms that affect daily functioning and long-term outcomes.

  • Cognitive impairment
  • Cognitive function
  • Adult schizophrenia

Its funded trial activity focuses on understanding treatment effects in adults living with schizophrenia, especially in relation to thinking, memory, and other cognitive domains.

Psychiatric Disorders

Clinical interest extends to the broader area of psychiatric disorders, with emphasis on symptoms that interfere with social and occupational functioning.

  • Neuropsychiatry
  • Functional impairment
  • Symptom management

The sponsor’s research activity is aligned with therapeutic questions relevant to persistent mental health burden in schizophrenia.

Neurocognitive Health

A key therapeutic domain is neurocognitive health, reflecting interest in how treatment may support attention, memory, and overall cognitive performance.

  • Attention
  • Memory
  • Executive function

This area highlights the sponsor’s focus on outcomes that are closely tied to independence and everyday functioning in people with schizophrenia.

Adult Mental Health

The sponsor is involved in research concerning adult mental health, particularly in populations living with chronic psychotic illness.

  • Adults with schizophrenia
  • Chronic psychiatric illness
  • Daily functioning

Its trial portfolio indicates interest in therapeutic strategies aimed at improving clinically meaningful outcomes for adults affected by schizophrenia.

Sponsored Trials

Trial Name Country Status
Efficacy of Xanomeline/Trospium in Adults with Schizophrenia for the Treatment of Cognitive Impairment: A Prospective Multicenter StudyAustria AustriaBelgium BelgiumCzechia CzechiaDenmark DenmarkGermany GermanyHungary HungaryItaly ItalySpain SpainThe Netherlands The NetherlandsNot Yet Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 2 total (0% not shared with other sponsors)

This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 15 sites collaborated multiple times

This sponsor has worked with 15 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Mental Disorders1 trial
    150 other sponsors

Partnered Research Centres

15 centres
location_city
assignment523
Azienda Ospedaliera Universitaria Citta' Della Salute E Della Scienza Di Torino
Address
Via Cherasco 15, 10126 Turin
Learn morearrow_forward
location_city
assignment283
Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli
Address
Piazza Luigi Miraglia 2, 80138 Naples
Learn morearrow_forward
location_city
assignment5
Bezirkskliniken Schwaben KU Anstalt des offentlichen Rechts des Bezirks Schwaben
Address
Geschwister-Schoenert-Strasse 1, Kriegshaber, 86156 Augsburg
Learn morearrow_forward
location_city
assignment1
Center for Neuropsychiatric Schizophrenia Research
Address
Nordre Ringvej 41, 2600 Glostrup Municipality
Learn morearrow_forward
location_city
assignment29
Central Institute of Mental Health
Address
Luisenring J 5, 68159 Mannheim
Learn morearrow_forward
location_city
assignment186
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Address
Villarroel 170, Department of Psychiatry and Psychology, Neuroscience Institute, 08036 Barcelona
Learn morearrow_forward
Page 1 of 3

Want to get in touch with this sponsor?

Send a question and we'll pass it on to European Group for Research in Schizophrenia Stichting.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.